These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 1501508)
1. The search for tumor-associated proteins in pleural effusions by means of monoclonal antibodies and a dot blot assay. Lawniczak M; Sikora J; Kania P; Zeromski J Lung; 1992; 170(2):65-74. PubMed ID: 1501508 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies in the cytodiagnosis of serous effusions. al-Nafussi A; Carder PJ Cytopathology; 1990; 1(2):119-28. PubMed ID: 1714782 [TBL] [Abstract][Full Text] [Related]
3. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion. Dong J; Sun G; Zhu H Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059 [TBL] [Abstract][Full Text] [Related]
5. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type]. Klech H; Rona G; Hutter C; Bayer PM; Kummer F Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811 [TBL] [Abstract][Full Text] [Related]
6. Immunophenotyping of mesothelial cells and carcinoma cells with monoclonal antibodies to cytokeratins, vimentin, CEA and EMA improves the cytodiagnosis of serous effusions. Daste G; Serre G; Mauduyt MA; Vincent C; Caveriviere P; Soleilhavoup JP Cytopathology; 1991; 2(1):19-28. PubMed ID: 1715202 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of a panel of molecular markers for the diagnosis of malignant serous effusions. Passebosc-Faure K; Li G; Lambert C; Cottier M; Gentil-Perret A; Fournel P; Pérol M; Genin C Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6862-7. PubMed ID: 16203775 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions. Salama G; Miédougé M; Rouzaud P; Mauduyt MA; Pujazon MC; Vincent C; Carles P; Serre G Br J Cancer; 1998; 77(3):472-6. PubMed ID: 9472646 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions. Ferrer J; Villarino MA; Encabo G; Felip E; Bermejo B; Vilà S; Orriols R Cancer; 1999 Oct; 86(8):1488-95. PubMed ID: 10526277 [TBL] [Abstract][Full Text] [Related]
10. Immunocytochemistry and ELISA quantitation of mucin for diagnosis of malignant pleural effusions. Yang PC; Luh KT; Kuo SH; Wu CW Am Rev Respir Dis; 1992 Dec; 146(6):1571-5. PubMed ID: 1456577 [TBL] [Abstract][Full Text] [Related]
11. Identification of carcinoma cells in ascitic and pleural fluid. Comparison of four panepithelial antigens with carcinoembryonic antigen. Mezger J; Stötzer O; Schilli G; Bauer S; Wilmanns W Acta Cytol; 1992; 36(1):75-81. PubMed ID: 1546516 [TBL] [Abstract][Full Text] [Related]
12. Elevated level of carcinoembryonic antigen in nonmalignant pleural effusions. Garcia-Pachon E; Padilla-Navas I; Dosda MD; Miralles-Llopis A Chest; 1997 Mar; 111(3):643-7. PubMed ID: 9118701 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic significance of cancer antigen 125, pancreatic oncofetal antigen, and carcinoembryonic antigen in malignant and tuberculous pleural effusions. Niwa Y; Shimokata K Jpn J Clin Oncol; 1986 Mar; 16(1):3-8. PubMed ID: 3009919 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of cancer antigen 15-3 (CA15-3) detected by monoclonal antibodies (115D8 and DF3) in exudative pleural effusions. Shimokata K; Totani Y; Nakanishi K; Yamamoto M; Hasegawa Y; Kawatsu H; Sasou H; Murate T; Ichiyama S; Kurasawa T Eur Respir J; 1988 Apr; 1(4):341-4. PubMed ID: 3165069 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients. Villena V; López-Encuentra A; Echave-Sustaeta J; Martín-Escribano P; Ortuño-de-Solo B; Estenoz-Alfaro J Cancer; 1996 Aug; 78(4):736-40. PubMed ID: 8756365 [TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies. Ghosh AK; Spriggs AI; Taylor-Papadimitriou J; Mason DY J Clin Pathol; 1983 Oct; 36(10):1154-64. PubMed ID: 6194183 [TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of various tumor markers in pleural effusion and in the serum]. Jibiki K; Abe Y; Takeda M; Iwachika C; Odagiri E; Demura R; Demura H Gan No Rinsho; 1989 Aug; 35(9):991-8. PubMed ID: 2769951 [TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical profile of benign and carcinomatous effusions. A practical approach to difficult diagnosis. Esteban JM; Yokota S; Husain S; Battifora H Am J Clin Pathol; 1990 Dec; 94(6):698-705. PubMed ID: 1700877 [TBL] [Abstract][Full Text] [Related]
19. Tumor-associated antigens in effusions of malignant and benign origin. Ammon A; Eiffert H; Reil S; Beyer JH; Droese M; Hiddemann W Clin Investig; 1993 Jun; 71(6):437-44. PubMed ID: 8353402 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of Her-2/neu, Cyfra 21-1, and carcinoembryonic antigen levels in malignant pleural effusions of lung adenocarcinoma. Huang WW; Tsao SM; Lai CL; Su CC; Tseng CE Pathology; 2010 Apr; 42(3):224-8. PubMed ID: 20350214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]